A blood test that could end the agony of miscarriages has come closer to reality after a team of scientists found a protein that helps babies stick to the womb.
The research found that monitoring levels of the protein, called Syncytin-1, which boosts the growth of the placenta and also helps embryos implant in the womb, could give doctors an early indication about whether an embryo will successfully implant.
This discovery paves the way for improved treatments for miscarriage and the potentially fatal condition pre-eclampsia.
Lead author Harry Moore said that eventually, they may be able to develop blood tests based on the results to identify pregnancies that might be at risk and also develop appropriate therapies.
He said that there is a lot on the news about the Zika virus infection at the moment and its devastating effects on foetal development but not all viral infections are necessarily as disastrous. Amazingly the Syncytin-1 gene is the result of a viral infection of our primate ancestors 25 million years ago.
The study is published in the journal Human Reproduction.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
